According to the Zhitong Finance App, Shandong Xinhua Pharmaceutical Co., Ltd. (00719) announced results for the nine months ended September 30, 2026, with operating income of 6.01 billion yuan (RMB, same below), a year-on-year decrease of 10.38%; net profit attributable to shareholders of listed companies was 195 million yuan, a year-on-year decrease of 23.88%; and basic earnings per share were 0.28 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.